SPRIM
SPRIM is a global health sciences company specializing in consulting, investment, and digital health solutions. With a presence on six continents and over 450 employees, SPRIM offers services across life sciences, healthcare, consumer health, and digital health sectors. The company is committed to building the future of health through innovation, strategic partnerships, and investment in startups. Its core practice areas include strategy & innovation, regulatory & scientific affairs, research & clinical services, and medical marketing & engagement. SPRIM's mission is to maximize the commercial potential of its clients by providing scientific and entrepreneurial expertise to develop innovative health solutions and address major health challenges.
Industries
Nr. of Employees
large (251-1000)
SPRIM
79 Science Park Drive #06-01/08 CINTECH IV Singapore 118264
Products
Integrated medical marketing tracking platform
Centralized software to host medical materials, capture field CRM interactions, run surveys, manage automated communications, deliver webinars and produce customizable dashboards for campaign optimization.
Decentralized clinical trial platform and mobile application
Mobile-first platform to run decentralized clinical studies with remote data capture, device integration, participant engagement and support for remote outcome assessments.
Algorithm-based non-invasive diagnostic tools
Diagnostic tools combining biometric inputs with algorithmic models to produce non-invasive screening and risk stratification outputs for clinical decision support.
Digital health risk assessment model
Algorithm-based digital model for broad-spectrum health assessment and risk stratification used to identify high-risk individuals and guide preventive interventions.
Integrated medical marketing tracking platform
Centralized software to host medical materials, capture field CRM interactions, run surveys, manage automated communications, deliver webinars and produce customizable dashboards for campaign optimization.
Decentralized clinical trial platform and mobile application
Mobile-first platform to run decentralized clinical studies with remote data capture, device integration, participant engagement and support for remote outcome assessments.
Algorithm-based non-invasive diagnostic tools
Diagnostic tools combining biometric inputs with algorithmic models to produce non-invasive screening and risk stratification outputs for clinical decision support.
Digital health risk assessment model
Algorithm-based digital model for broad-spectrum health assessment and risk stratification used to identify high-risk individuals and guide preventive interventions.
Services
Science-driven product and business concept development, market strategy, innovation planning and commercialization support across health, consumer and digital health sectors.
Comprehensive regulatory services including market feasibility, claim analysis, dossier development, submission management and regulatory advocacy to support global market entry across food, supplements, cosmetics, pharma and devices.
Turnkey clinical research services including study design, protocol development, trial execution, decentralized operations, remote data capture and publication support.
Medical communications, KOL engagement, patient engagement and adherence program design, digital marketing analytics, and campaign implementation tied to scientific evidence.
Equity, debt and royalty financing for clinical-stage biotech, medtech and digital health companies, plus operational and commercial support from a venture portfolio.
Advisory and implementation services for AI/ML analytics, digital biomarker development, mobile health solutions and decentralized trial enablement.
Science-driven product and business concept development, market strategy, innovation planning and commercialization support across health, consumer and digital health sectors.
Comprehensive regulatory services including market feasibility, claim analysis, dossier development, submission management and regulatory advocacy to support global market entry across food, supplements, cosmetics, pharma and devices.
Turnkey clinical research services including study design, protocol development, trial execution, decentralized operations, remote data capture and publication support.
Medical communications, KOL engagement, patient engagement and adherence program design, digital marketing analytics, and campaign implementation tied to scientific evidence.
Equity, debt and royalty financing for clinical-stage biotech, medtech and digital health companies, plus operational and commercial support from a venture portfolio.
Advisory and implementation services for AI/ML analytics, digital biomarker development, mobile health solutions and decentralized trial enablement.
Expertise Areas
- Clinical trial management (including decentralized trials)
- Digital health product development and mobile health
- Medical marketing, KOL engagement and HCP communications
- Regulatory strategy, market access and global product registration
Key Technologies
- Artificial intelligence and machine learning
- Natural language processing for regulatory and evidence queries
- Decentralized clinical trial platforms and mobile applications
- Digital biomarker development and analytic validation
News & Updates
Vanteres, an innovative biotech company leveraging its biomedical research expertise to develop actively transported lysophospholipids, announces new evidence that demonstrates the critical role of LPC-DHA in normal fetal and infant brain development.
ObvioHealth, a global medical technology company, announces the launch of its mobile application for site-less clinical studies— the ObvioHealth app. The app removes barriers currently troubling the clinical research industry by improving convenience for study subjects, enhancing compliance.
ObvioHealth, a Singapore and Orlando-based company offering mobile and “site-less” clinical trials, said on Friday it has raised US$3 million in Series A funding. The company is focused on making clinical trials faster and more cost-effective by digitizing the entire process.
ObvioHealth, supported by SPRIM, releases a mobile app to revolutionize clinical studies.
Evid Science’s CEO discusses how AI is transforming healthcare by making scientific data more accessible.
A study published in Nutrition Journal found that A2 beta casein milk reduces gastrointestinal symptoms.
Vanteres, an innovative biotech company leveraging its biomedical research expertise to develop actively transported lysophospholipids, announces new evidence that demonstrates the critical role of LPC-DHA in normal fetal and infant brain development.
ObvioHealth, a global medical technology company, announces the launch of its mobile application for site-less clinical studies— the ObvioHealth app. The app removes barriers currently troubling the clinical research industry by improving convenience for study subjects, enhancing compliance.
ObvioHealth, a Singapore and Orlando-based company offering mobile and “site-less” clinical trials, said on Friday it has raised US$3 million in Series A funding. The company is focused on making clinical trials faster and more cost-effective by digitizing the entire process.
ObvioHealth, supported by SPRIM, releases a mobile app to revolutionize clinical studies.
Evid Science’s CEO discusses how AI is transforming healthcare by making scientific data more accessible.
A study published in Nutrition Journal found that A2 beta casein milk reduces gastrointestinal symptoms.